GLAXOSMITHKLINE PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,104 INR | +0.79% |
|
+8.28% | +10.86% |
| 04-25 | GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | RE |
| 03-22 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
Evolution of the average Target Price on GlaxoSmithKline Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
1719a5ae84a8f583ee6.8qSxdS4zuqdrZEg5vQ4YXWkTkW_bBbti2dajYW8g4oE.xMLkRHwGg_9bNC9J70csC1Fy_gKCRv1R6Yz5ACwRm-7E7t8FSESDwDEqBQ~a71ec5edef4ca9fef1e9b0d66c47c60e
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,104
INR
Average target price
2,141
INR
Spread / Average Target
+1.79%
High Price Target
2,450
INR
Spread / Highest target
+16.47%
Low Price Target
1,895
INR
Spread / Lowest Target
-9.91%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- GLAXO Stock
- Consensus GlaxoSmithKline Pharmaceuticals Limited
